237 related articles for article (PubMed ID: 10586536)
1. The effects of clozapine on levels of total cholesterol and related lipids in serum of patients with schizophrenia: a prospective study.
Dursun SM; Szemis A; Andrews H; Reveley MA
J Psychiatry Neurosci; 1999 Nov; 24(5):453-5. PubMed ID: 10586536
[TBL] [Abstract][Full Text] [Related]
2. [A new therapeutic approach tp drug-resistant schizophrenia: clozapine. Long-term prospective study in 16 patients].
Jalenques I; Coudert AJ
Acta Psychiatr Belg; 1992; 92(6):323-38. PubMed ID: 1364281
[TBL] [Abstract][Full Text] [Related]
3. Clinical predictors of therapeutic response to clozapine in a sample of Turkish patients with treatment-resistant schizophrenia.
Semiz UB; Cetin M; Basoglu C; Ebrinc S; Uzun O; Herken H; Balibey H; Algul A; Ates A
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Aug; 31(6):1330-6. PubMed ID: 17618026
[TBL] [Abstract][Full Text] [Related]
4. Sex difference in effects of typical and atypical antipsychotics on glucose-insulin homeostasis and lipid metabolism in first-episode schizophrenia.
Wu RR; Zhao JP; Zhai JG; Guo XF; Guo WB
J Clin Psychopharmacol; 2007 Aug; 27(4):374-9. PubMed ID: 17632222
[TBL] [Abstract][Full Text] [Related]
5. Amisulpride augmentation in patients with schizophrenia partially responsive or unresponsive to clozapine. A randomized, double-blind, placebo-controlled trial.
Assion HJ; Reinbold H; Lemanski S; Basilowski M; Juckel G
Pharmacopsychiatry; 2008 Jan; 41(1):24-8. PubMed ID: 18203048
[TBL] [Abstract][Full Text] [Related]
6. Effects of clozapine and typical antipsychotic drugs on plasma 5-HT turnover and impulsivity in patients with schizophrenia: a cross-sectional study.
Dursun SM; Szemis A; Andrews H; Whitaker P; Reveley MA
J Psychiatry Neurosci; 2000 Sep; 25(4):347-52. PubMed ID: 11022399
[TBL] [Abstract][Full Text] [Related]
7. Management of antipsychotic-induced weight gain: prospective naturalistic study of the effectiveness of a supervised exercise programme.
Poulin MJ; Chaput JP; Simard V; Vincent P; Bernier J; Gauthier Y; Lanctôt G; Saindon J; Vincent A; Gagnon S; Tremblay A
Aust N Z J Psychiatry; 2007 Dec; 41(12):980-9. PubMed ID: 17999270
[TBL] [Abstract][Full Text] [Related]
8. Treatment pathway and patterns of clozapine prescribing for schizophrenia in New Zealand.
Wheeler AJ
Ann Pharmacother; 2008 Jun; 42(6):852-60. PubMed ID: 18477732
[TBL] [Abstract][Full Text] [Related]
9. Biogenic amines as predictors of response to clozapine treatment in early-onset schizophrenia.
Fleischhaker C; Schulz E; Remschmidt H
J Psychiatr Res; 1998; 32(5):325-33. PubMed ID: 9789212
[TBL] [Abstract][Full Text] [Related]
10. [Effect of clozapine on biogenic amines within the scope of drug treatment of schizophrenic psychoses in adolescence].
Schulz E; Remschmidt H; Fleischhaker C
Z Kinder Jugendpsychiatr; 1994 Dec; 22(4):285-98. PubMed ID: 7856324
[TBL] [Abstract][Full Text] [Related]
11. Clinical response to clozapine treatment of 11 chronic patients in a state psychiatric hospital.
Herman M
Aust N Z J Ment Health Nurs; 1997 Sep; 6(3):129-33. PubMed ID: 9384012
[TBL] [Abstract][Full Text] [Related]
12. Randomized controlled trial of the effect on Quality of Life of second- vs first-generation antipsychotic drugs in schizophrenia: Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study (CUtLASS 1).
Jones PB; Barnes TR; Davies L; Dunn G; Lloyd H; Hayhurst KP; Murray RM; Markwick A; Lewis SW
Arch Gen Psychiatry; 2006 Oct; 63(10):1079-87. PubMed ID: 17015810
[TBL] [Abstract][Full Text] [Related]
13. Clozapine-induced electroencephalogram changes as a function of clozapine serum levels.
Freudenreich O; Weiner RD; McEvoy JP
Biol Psychiatry; 1997 Jul; 42(2):132-7. PubMed ID: 9209730
[TBL] [Abstract][Full Text] [Related]
14. Violence and schizophrenia: clozapine as a specific antiaggressive agent.
Buckley P; Bartell J; Donenwirth K; Lee S; Torigoe F; Schulz SC
Bull Am Acad Psychiatry Law; 1995; 23(4):607-11. PubMed ID: 8639988
[TBL] [Abstract][Full Text] [Related]
15. Clinical effects of a randomized switch of patients from clozaril to generic clozapine.
Kluznik JC; Walbek NH; Farnsworth MG; Melstrom K
J Clin Psychiatry; 2001; 62 Suppl 5():14-7; discussion 23-4. PubMed ID: 11305843
[TBL] [Abstract][Full Text] [Related]
16. [Depressive symptoms and biogenic amines as predictors of treatment response in schizophrenic illnesses in childhood and adolescence].
Fleischhaker C; Schulz E; Remschmidt H
Z Kinder Jugendpsychiatr Psychother; 1998 Dec; 26(4):235-43. PubMed ID: 9880833
[TBL] [Abstract][Full Text] [Related]
17. Initial experience with clozapine in Woodbridge Hospital.
Wong KE; Chong SA; Ngui F; Winslow M; Devan GS; Leong OK; Choo CH
Singapore Med J; 1997 Aug; 38(8):336-8. PubMed ID: 9364887
[TBL] [Abstract][Full Text] [Related]
18. The brief psychiatric rating scale: effect of scaling system on clinical response assessment.
Thompson PA; Buckley PF; Meltzer HY
J Clin Psychopharmacol; 1994 Oct; 14(5):344-6. PubMed ID: 7806691
[TBL] [Abstract][Full Text] [Related]
19. [Clozapine and refractory schizophrenia. Long-term prospective study of 20 patients].
Jalenques I; Coudert AJ
Encephale; 1994; 20(6):767-75. PubMed ID: 7875111
[TBL] [Abstract][Full Text] [Related]
20. LDL cholesterol estimation using the Anandaraja's and Friedewald's formulas in schizophrenic patients treated with antipsychotic drugs.
Paz E; Hermida J; Bouzas L; Brenlla J; Tutor JC
Clin Biochem; 2008 Aug; 41(12):1002-7. PubMed ID: 18474233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
